Tonix Pharmaceuticals Holding Corp (TNXP)
0.1933
0.00 (0.00%)
USD |
NASDAQ |
Nov 26, 16:00
0.1929
0.00 (0.00%)
After-Hours: 20:00
Tonix Pharmaceuticals Revenue (TTM): 11.29M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 11.29M |
Date | Value |
---|---|
June 30, 2024 | 12.46M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
11.29M
Minimum
Sep 2024
12.46M
Maximum
Jun 2024
11.87M
Average
11.87M
Median
Revenue (TTM) Benchmarks
Abbott Laboratories | 41.22B |
Emergent BioSolutions Inc | 1.094B |
Geovax Labs Inc | -- |
Amicus Therapeutics Inc | 493.67M |
Chimerix Inc | -- |